About CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
Clinical Trials at CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
During the past decade, CIRI - Centrum für Innovative Diagnostik und Therapie GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH"
#1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Goethe University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
According to Clinical.Site data, the most researched conditions in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH" are
"Rheumatoid Arthritis" (4 trials), "Osteoarthritis, Hip" (1 trials), "Osteoarthritis, Knee" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH" in a lesser frequency.
Clinical Trials Intervention Types at CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
Most popular intervention types in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Adalimumab 40mg q2w" (1 trials), "Methotrexate" (1 trials), "Olokizumab" (1 trials) and "Olokizumab 64mg q2w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
The vast majority of trials in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH" are
6 trials for "All" genders.
Clinical Trials Status at CIRI - Centrum für Innovative Diagnostik und Therapie GmbH
Currently, there are NaN active trials in "CIRI - Centrum für Innovative Diagnostik und Therapie GmbH".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in CIRI - Centrum für Innovative Diagnostik und Therapie GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CIRI - Centrum für Innovative Diagnostik und Therapie GmbH, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".